Endogenous superallergen protein Fv induces IL-4 secretion from human FcεRI+ cells through interaction with the V(H)3 region of IgE

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5647-5655

  Patella, Vincenzo ^a   Giuliano, Ada ^b   Bouvet, Jean Pierre ^c   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ARTICLE; BASOPHIL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; VIRUS HEPATITIS;

ADULT; ALLERGENS; ANTIBODIES, ANTI-IDIOTYPIC; BASOPHILS; CYCLOSPORINE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; INTERLEUKIN-4; KINETICS; LACTIC ACID; LUNG; LYMPHOKINES; MAST CELLS; MYELOMA PROTEINS; RECEPTORS, IGE; RNA, MESSENGER; SIALOGLYCOPROTEINS; SUPERANTIGENS; TACROLIMUS;

EID: 0032533829     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Bouvet, J.-P., R. Pirès, F. Lunel-Fabiani, B. Crescenzo-Chaigne, P. Maillard, D. Valla, P. Opolon, and J. Pillot. 1990. Protein F: a novel F(ab)-binding factor present in normal liver and largely released in the digestive tract during hepatitis. J. Immunol. 145:1176.
2. 2-binding molecule (protein Fv) in mucosal immunity. In Current Topics in Mucosal Immunology 1993. M. Tsuchiya, J. Yodoi, T. Hibi, and S. Miura, eds. Experta Medica, Tokyo, pp. 169-174.
3. Bouvet, J.-P., R. Pirès, J. Charlemagne, J. Pillot, and S. Iscaki. 1991. Non-immune binding of human protein Fv to immunoglobulins from various mammalian and non-mammalian species. Scand. J. Immunol. 34:491.
4. H-binding specificity of human protein Fv. Scand. J. Immunol. 33:381.
5. Silverman, G. J., P. Roben, J.-P. Bouvet, and M. Sasano. 1995. Superantigen properties of a sialoprotein involved in gut associated immunity. J. Clin. Invest. 96:417.
6. H family-specific binding interactions with human Igs. J. Immunol. 157:4496.
7. Silverman, G. J. 1997. B-cell superantigen. Immunol. Today 18:379.
8. Weiss, T. D., C. C. Tsai, A. R. Baldassare, and J. Zuckner. 1978. Skin lesions in viral hepatitis: histologic and immunofluorescent findings. Am. J. Med. 64:269.
9. Popp, J. W., Jr., T. J. Harrist, J. L. Dienstag, A. K. Bhan, J. R. Wands, J. T. LaMont, and M. C. Mihm, Jr. 1981. Cutaneous vasculitis associated with acute and chronic hepatitis. Arch. Intern. Med. 141:623.
10. Segool, R. A., C. Lejtenyi, and L. M. Taussig. 1975. Articular and cutaneous prodromal manifestations of viral hepatitis. J. Pediatrics 87:709.
11. Vaida, G. A., M. A. Goldman, and K. J. Bloch. 1983. Testing for hepatitis B virus in patients with chronic urticaria and angioedema. J. Allergy Clin. Immunol. 72:193.
12. Miadonna, A., A. Tedeschi, E. Leggieri, F. Invemizzi, and C. Zanussi. 1982. Basophil activation in idiopathic mixed cryoglobulinemia. J. Clin. Immunol. 2:309.
13. Marone, G., M. Columbo, M. Triggiani, R. Cirillo, A. Genovese, and S. Formisano. 1987. Inhibition of IgE-mediated histamine and peptide leukotriene release from human basophils and mast cells by forskolin. Biochem. Pharmacol. 36:13.
14. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346:274.
15. Walsh, L. J., G. Trinchieri, H. A. Waldorf, D. Whitaker, and G. F. Murphy. 1991. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88:4220.
16. Bradding, P., I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, J. P. A. Bews, T. C. Hunt, Y. Okayama, C. H. Heusser, G. R. Bullock, M. K. Church, and S. T. Holgate. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381.
17. Brunner, T., C. H. Heusser, and C. A. Dahinden. 1993. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177:605.
18. MacGlashan, D., Jr., J. M. White, S.-K. Huang, S. J. Ono, J. T. Schroeder, and L. M. Lichtenstein. 1994. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J. Immunol. 152:3006.
19. Schroeder, J. T., L. M. Lichtenstein, and S. M. MacDonald. 1997. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils. J. Immunol. 159:447.
20. Ochensberger, B., G.-C. Daepp, S. Rihs, and C. A. Dahinden. 1996. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 88:3028.
21. Li, H., T. C. Sim, J. A. Grant, and R. Alam. 1996. The production of macrophage inflammatory protein-1α by human basophils. J. Immunol. 157:1207.
22. Hatamochi, A., K. Fujiwara, and H. Ueki. 1985. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch. Dermatol. Res. 277:60.
23. Gruber, B. L., R. K. Richard, A. Jelaska, M. J. Marchese, J. Garlik, S. Ren, L. B. Schwartz, and J. H. Korn. 1997. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 158:2310.
24. Biagini, G., and G. Ballardini. 1989. Liver fibrosis and extracellular matrix. J. Hepatol. 8:115.
25. + T cells, interleukin 4 production is cytokine-autonomous, whereas interferon γ production is cytokine-dependent. Proc. Natl. Acad. Sci. USA 94:3189.
26. Del Prete, G., E. Maggi, P. Parronchi, I. Chrétien, A. Tiri, D. Macchia, M. Ricci, J. Banchereau, J. de Vries, and S. Romagnani. 1988. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 140:4193.
27. 2. Proc. Natl. Acad. Sci. USA 85:6880.
28. 2. Proc. Natl. Acad. Sci. USA 86:3803.
29. Sozzani, P., C. Cambon, N. Vita, M.-H. Séguélas, D. Caput, P. Ferrara, and B. Pipy. 1995. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes: role of calcium and cyclic AMP. J. Biol. Chem. 270:5084.
30. Schleimer, R. P., S. A. Sterbinsky, J. Kaiser, C. A. Bickel, D. A. Klunk, K. Tomioka, W. Newman, F. W. Luscinskas, M. A. Gimbrone, Jr., B. W. McIntyre, and B. S. Bochner. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J. Immunol. 148:1086.
31. Tepper, R. I., P. K. Pattengale, and P. Leder. 1989. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503.
32. Croft, M., L. Carter, S. L. Swain, and R. W. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
33. Patella, V., J.-P. Bouvet, and G. Marone. I993. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J. Immunol. 151:5685.
34. de Paulis, A., R. Cirillo, A. Ciccarelli, G. de Crescenzo, A. Oriente, and G. Marone. 1991. Characterization of the antiinflammatory effect of FK-506 on human mast cells. J. Immunol. 147:4278.
35. Marone, G., M. Tamburini, M. G. Giudizi, R. Biagiotti, F. Almerigogna, and S. Romagnani. 1987. Mechanism of activation of human basophils by Slaphylococcus aureus Cowan 1. Infect. Immun. 55:803.
36. Bouvet, J.-P., R. Pirès, and J. Pillot. 1984. A modified gel filtration technique producing an unusual exclusion volume of IgM: a simple way of preparing monoclonal IgM. J. Immunol. Methods 66:299.
37. Patella, V., V. Casolaro, A. Ciccarelli, G. R. Pettit, M. Columbo, and G. Marone. 1995. The antineoplastic bryostatins affect differently human basophils and mast cells. Blood 85:1272.
38. Gilbert, H. S., and L. Ornstein. 1975. Basophil counting with a new staining method using Alcian blue. Blood 46:279.
39. Siraganian, R. P. 1974. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem. 57:383.
40. Snedecor, G. W., and W. G. Cochran. 1980. Statistical Methods. Iowa State University Press, Ames, IA.
41. Cirillo, R., M, Triggiani, L. Siri, A. Ciccarelli, G. R. Pettit, M. Condorelli, and G. Marone. 1990. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J. Immunol. 144:3891.
42. Casolaro, V., G. Spadaro, V. Patella, and G. Marone. 1993. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. J. Immunol. 151:5563.
43. Marone, G., V. Casolaro, R. Paganelli, and I. Quinti. 1989. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J. Invest. Dermatol. 93:246.
44. Riske, F., J. Hakimi, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Ling, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (Fc∈RI): analysis of functional domains of the α-subunit with monoclonal antibodies. J. Biol. Chem. 266:11245.
45. Bombardieri, S., P. Paoletti, C. Ferri, O. Di Munno, E. Fornai, and C. Giuntini. 1979. Lung involvement in essential mixed cryoglobulinemia. Am. J. Med. 66: 748.
46. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327:1490.
47. Dammacco, F., and D. Sansonno. 1992. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin. Exp. Immunol. 87:352.
48. Bouvet, J.-P., R. Pire∈s, R. Isaki, and J. Pillot. 1993. Nonimmune macromolecular complexes of Ig in human gut lumen: probable enhancement of antibody functions. J. Immunol. 151:2562.
49. Marone, G., A. Kagey-Sobotka, and L. M. Lichtenstein. 1981. IgE-mediated histamine release from human basophils: differences between antigen E- and anti-IgE-induced secretion. Int. Arch. Allergy Appl. Immunol. 65:339.
50. MacGlashan, D. W., Jr., S. P. Peters, J. Warner, and L. M. Lichtenstein. 1986. Characteristics of sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J. Immunol. 136:2231.
51. Heiner, D. C., and B. Rose. 1970. Elevated levels of γE (IgE) in conditions other than classical allergy. J. Allergy 45:30.
52. Van Epps, E., G. Husby, R. C. Williams, Jr., and R. G. Strickland. 1976. Liver disease-a prominent cause of serum IgE elevation. Clin. Exp. Imuunol. 23:444.
53. Joske, R. A., K. J. Turner, and B. P. Murphy. 1976. Serum IgE levels in patients with liver disease. Med. J. Aust. 2:555.
54. Yano, K., M. Yamaguchi, F. de Mora, C. S. Lantz, J. H. Butterfield, J. J. Costa, and S. J. Galli. 1997. Production of macrophage inflammatory protein-1α by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77:185.
55. + T lymphocyte chemoattractant factor. IL-16. J. Immunol. 159:2904.
56. Marone, G., V. Casolaro, V. Patella, G. Florio, and M. Triggiani. 1997. Molecular and cellular biology of mast cells and basophils. Im. Arch. Allergy Immunol. 114:207.
57. Lock, S. H., B. Kay, and N. C. Barnes. 1996. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med. 153:509.
58. Ruzicka, T., T. Bieber, E. Schöpf, A. Rubins, A. Dobozy, J. D. Bos, Jablonska, I. Ahmed, K. Thestrup-Pedersen, F. Daniel, A. Finzi, and S. Reitamo. 1997. A short-term trial of tacrolimus ointment for atopic dermatitis. N. Engl. J. Med. 337:816.
59. Galli, S. J. 1990. New insights into "the riddle of the mast cells": microevironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5.
60. Shaikh, N., J. Rivera, B. R. Hewlett, R. H. Stead, F.-G. Zhu, and J. S. Marshall. 1997. Mast cell Fc∈RI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE. J. Immunol. 158:3805.
61. Bouvet, J.-P., and G. Dighiero. 1998. From natural polyreactive autoantibodies to à la carte monoreactive antibodies to infections agents: is it a small world after all? Infect. Immun. 66:1.
62. H3 family antibodies bind domain D of staphylococcal protein A. J. Immunol. 154:6437.
63. Goodglick, L., N. Zevit, M. S. Neshat, and J. Braun. 1995. Mapping the Ig superantigen-binding site of HIV-1 gp120. J. Immunol. 155:5151.
64. Karray, S., and M. Zouali. 1997. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. USA 94:1356.
65. Viganó, A., N. Principi, L. Crupi, J. Onorato, G. V. Zuccotti, and A. Salvaggio. 1995. Elevation of IgE in HIV-infected children and its correlation with the progression of disease. J. Allergy Clin. Immunol. 95:627.
66. + cell response against human immunodeficiency virus: implications for long-term survival. Proc. Natl. Acad. Sci. USA 92:11135.